Green chemistry: BAM investigates pharmaceutical production without solvents and CO₂ emissions

Pharmaceutical production with mechanochemistry

28-Nov-2022 - The Bundesanstalt für Materialforschung und -prüfung (BAM) is developing a more sustainable process to produce active pharmaceutical ingredients in a major EU project: The pilot project is intended to demonstrate the advantages of mechanochemistry for more environmentally friendly and CO2-neutral ...

Merck Invests € 250 Million in Production Value Chain in China

04-Nov-2016 - Merck inaugurated its € 170 million Nantong pharmaceutical plant, which is dedicated to producing high-quality pharmaceuticals on China’s Essential Drug List. At the inauguration ceremony, Merck also announced a further investment of around € 80 million in a Life Science Center near the Nantong ...

L.B. Bohle: State-of-the-Art Equipment for Trials in the Service Center

New Technology: TriPan Coater BFC 50 Is the Latest Generation and GMA in Combination with the BFS 30 Fluid Bed

22-Sep-2016 - L.B. Bohle Maschinen + Verfahren GmbH has installed the new machines at the Service Center in order to offer its customers the latest machine generation for test trials. The Service Center was first opened in 2005 at Bohle’s headquarters in Ennigerloh. On more than 500 m², the center offers ...

Investing in the future: Bohle Technology Center to be opened in March 2015

24-Nov-2014 - Despite a reserved investment climate in the pharmaceutical industry, L.B. Bohle Maschinen + Verfahren GmbH has used the 2014 financial year to prepare itself for the future – with a multi-million euro investment. The new Technology Center at its headquarters in Ennigerloh will open in March ...

Siegfried facility in Nantong receives operating approval

28-Oct-2014 - Siegfried received operating approval for Phase I of the production plant for active pharmaceutical ingredients at its new facility in Nantong, near Shanghai, China. Validation of the new plant commences with production in the pilot plant. Siegfried plans to produce first commercial batches in ...

Merck Serono Announces Groundbreaking of New Pharmaceutical Manufacturing Facility in China

29-Aug-2014 - Merck Serono held the groundbreaking ceremony for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be the Group’s second-largest pharmaceutical manufacturing facility worldwide, will focus on the bulk production and packaging of Glucophage®, Concor® ...

Merck Strengthens its Presence in China with New Pharmaceutical Manufacturing Facility

19-Nov-2013 - Merck announced a € 80 million investment in a new pharmaceutical manufacturing facility, to be located in the Nantong Economical Technological Development Area (NETDA), in the Greater Shanghai region (Yangtze River Delta area). “This further investment in China reflects Merck’s long-term ...